NCT00002105View on ClinicalTrials.gov

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

PHASE3CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

Not specified

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Doxorubicin hydrochloride (liposomal)

DRUG

Bleomycin sulfate

DRUG

Vincristine sulfate

Trial Locations (4)

10029

Mount Sinai Med Ctr, New York

77074

Twelve Oaks Hosp, Houston

98101

Virginia Mason Research Center / Clinical Trial Unit, Seattle

02215

Beth Israel Hosp, Boston

All Listed Sponsors

lead

Sequus Pharmaceuticals

INDUSTRY

NCT00002105 - Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter